Halozyme Therapeutics shares owned by Mizuho Markets Americas
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Mizuho Markets Americas
from 13F filings
Historical chart of Mizuho Markets Americas investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Mizuho Markets Americas consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Halozyme Therapeutics by Mizuho Markets Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $25M | 342k | 73.34 |
| 2025-06-30 | $21M | 397k | 52.02 |
| 2025-03-31 | $24M | 374k | 63.81 |
| 2024-12-31 | $22M | 467k | 47.81 |
| 2024-09-30 | $22M | 375k | 57.24 |
| 2024-06-30 | $23M | 438k | 52.36 |
| 2024-03-31 | $19M | 457k | 40.68 |
| 2023-12-31 | $17M | 447k | 36.96 |
| 2023-09-30 | $15M | 403k | 38.20 |
| 2023-06-30 | $15M | 403k | 36.07 |
| 2023-03-31 | $14M | 359k | 38.19 |
| 2022-12-31 | $16M | 275k | 56.90 |
| 2022-09-30 | $14M | 359k | 39.54 |